WuXi Advanced Therapies’ Philadelphia Site Approved by FDA to Start Manufacturing Iovance’s Melanoma T-cell Therapy

Amtagvi is the first one-time, individualized T-cell therapy approved by the FDA for any solid tumor cancer.